LifeSci Acquisition II Corp (LSAQ)

Etorro trading 970x250

About LifeSci Acquisition II Corp

LifeSci Acquisition II Corp. intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities in the healthcare industry. The company was founded in 2019 and is based in New York, New York. Address: 250 West 55th Street, New York, NY, United States, 10019

LifeSci Acquisition II Corp News and around…

Latest news about LifeSci Acquisition II Corp (LSAQ) common stock and company :

With SPAC deal done, Triangle science company hits public markets
07 Oct, 2021 Yahoo! Finance

A clinical research organization is the latest Triangle firm to go public after merging with a special purpose acquisition company.

Science 37, the Operating System for Agile Clinical Trials, Closes Business Combination with LifeSci Acquisition II Corp. and Will Begin Trading on Nasdaq as SNCE
07 Oct, 2021 Yahoo! Finance

Science 37 to debut on Nasdaq as a publicly traded company under ticker symbol “SNCE”Business combination will provide Science 37 with approximately $235 million in cash proceeds to support continued growthScience 37 to fuel its mission to enable universal access to clinical research which has proven to accelerate patient enrollment, minimize patient burden, and include underserved patient populations Investments targeted to enhance the Science 37 Operating System to decentralize clinical trial

October SPAC Merger Calendar: A Look At Upcoming Votes, Stocks To Watch
04 Oct, 2021 FinancialContent

The month of October marks a slowdown in SPAC merger deal votes, but the calendar does include several multibillion-dollar ...

LifeSci Acquisition II Corp. Announces Confidential Submission of S-4 Registration Statement Related to Proposed Business Combination
16 Jun, 2021 FinancialContent
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of LifeSci Acquisition II Corp. Merger
12 May, 2021 FinancialContent
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of LifeSci Acquisition II Corp. - LSAQ
12 May, 2021 Yahoo! Finance

Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating LifeSci Acquisition II Corp. ("LSAQ" or the "Company") (LSAQ) relating to its proposed merger with Science 37, Inc. Under the terms of the agreement, LSAQ will acquire Science 37 through a reverse merger, with Science 37 emerging as a publicly traded company.

Moore Kuehn Encourages MNR, LOKB, LSAQ and MFNC Investors to Contact Law Firm
11 May, 2021 FinancialContent
On The Fly: The Week In SPAC News - Sunday, May 9
09 May, 2021 FinancialContent

In SPAC news this week, gym operator Equinox is said to be in talks to go public, while Roivant Sciences and Montes Archimedes Acquisition Corp. announced that they have entered into a merger agreement.

'SPACs Attack' Recap: Looking Back At 5 SPAC Deals, Rumors And Top Headlines
08 May, 2021 FinancialContent

Last week featured five announced SPAC deals and several rumors. The week also had earnings from several well-known former SPACs. Here ...

SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of LifeSci Acquisition II Corp. (Nasdaq – LSAQ)
07 May, 2021 Yahoo! Finance

BALA CYNWYD, PA / ACCESSWIRE / May 7, 2021 / Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of LifeSci Acquisition II Corp. ("LifeSci II" or the "Company") (Nasdaq:LSAQ) for possible breaches of fiduciary duty and other violations of federal and state law in connection with a merger agreement pursuant to which LifeSci II, a special purpose acquisition company, will combine with Science 37, Inc.

Science 37 Taps SPAC For NASDAQ Listing Valued At Around $1B
07 May, 2021 FinancialContent

Science 37, a life science company, is tapping the craze of a special purpose acquisition company to help it with a major public ...

Science 37 to Become Publicly Listed via Merger with LifeSci Acquisition II Corp., Powering the Clinical Trial Operating System of the Future
07 May, 2021 FinancialContent

Science 37, Inc. and LifeSci Acquisition II Corp announced that they have entered into a definitive business combination agreement.

LifeSci Acquisition II Corp. Announces Pricing of $75 Million Initial Public Offering
20 Nov, 2020 FinancialContent

LifeSci Acquisition II Corp (LSAQ) is a NASDAQ Common Stock listed in , ,

970x250